OOIR: Observatory of International Research

Papers

(The median citation count of Therapeutic Advances in Musculoskeletal Disease is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Is there wastage in the research resources for ankylosing spondylitis? An analysis of clinical trial discontinuation and nonpublication outcome	95
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment	46
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis	39
Stakeholder perspectives on musculoskeletal pain assessment and management in the UK: a qualitative study	37
Mapping emotional function in fibromyalgia: integrating alexithymia, pain catastrophizing, and self-compassion	31
Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI	31
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis	31
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset	30
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study	30
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients	29
Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis	27
Patients with poorer health status are more likely to have difficult-to-manage axial spondyloarthritis: insights from a real-world cohort	23
Cardio-rheumatology: integrated care and the opportunities for personalized medicine	21
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs	20
Reduced bone mineral density in patients with idiopathic inflammatory myopathies: a case-control study	18
The association between glucagon-like peptide-1 receptor agonist and rheumatoid arthritis: a population-based case–control study	17
Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension	16
From advanced imaging to molecular insights: the state of the art in omics for axial spondyloarthritis	15
Plain language summary: gout remission with pegloticase	15
Recurrent uveitis unveiling axial spondyloarthritis: is inflammatory back pain always the main road to diagnosis? A monocentric cohort	15
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes	14
Early knee OA definition–what do we know at this stage? An imaging perspective	14
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout	14
Role of imaging for eligibility and safety of a-NGF clinical trials	13
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial	13

T -score discordance between hip and lumbar spine: risk factors and clinical implications	13
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses	13
Artificial intelligence in Kellgren–Lawrence grading of knee osteoarthritis: bridging radiographic tradition with algorithmic precision	12
Development and evaluation of a multivariable prediction model for clinical improvement in an established cohort of Colombian rheumatoid arthritis patients	12
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosi	12
A transfer learning–based approach for automated bone fracture classification in X-ray imaging	11
Psoriatic arthritis management: a comparative analysis of PANLAR, EULAR, and GRAPPA treatment recommendations	11
Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis	11
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care	11
Implementation of clinical decision support tools for treatment selection in knee osteoarthritis: a scoping review	11
Advanced imaging techniques in crystal arthritis	11
Systemic lupus erythematosus is associated with increased risk of Parkinson’s disease	11
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers	10
A novel infrapatellar approach of ultrasound-guided intra-articular injection of the knee from both lateral and medial side: a case series	10
Early identification of difficult-to-manage axial spondyloarthritis using machine-learning decision trees	9
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review	9
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multipl	9
The analysis of the pulmonary domain involvement in Sjögren’s disease	9
Gout therapy updated	9
Towards an individualised approach to pain management in inflammatory arthritis	8
Development and validation of a clinical scoring system for the prediction of methotrexate treatment response in rheumatoid arthritis patients: a multicenter real-world study	8
Precision medicine using molecular-target drugs in psoriatic arthritis	8
Associations of muscle mass, adipose tissue mass, and skeletal muscle radiodensity with disease activity in axial spondyloarthritis	7
Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate	7
Ultrasound evaluation of finger joint cartilage damage progression in patients with rheumatoid arthritis	7
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy	7
Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy	7
Precision medicine in axial spondyloarthritis: current opportunities and future perspectives	7
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose	6
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic	6
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)	6
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab	6
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthr	6
Precision imaging biomarkers for gout: artifact-specific spectral CT parameters for personalized differentiation of tophi in a prospective study	6
Latest insights in disease-modifying osteoarthritis drugs development	6
The application of machine learning in early diagnosis of osteoarthritis: a narrative review	6
Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients	5
Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapies	5
Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANE	5
The burden of low back pain in children and adolescents with overweight and obesity: from pathophysiology to prevention and treatment strategies	5
Effectiveness and safety of neridronate in chronic nonbacterial osteomyelitis: insight from the CAMELOT registry	5
Evaluation of hematological parameters as biomarkers of disease activity in drug-naïve patients with rheumatoid arthritis: a retrospective analysis	5
Meibomian gland dropout of upper eyelids as a novel biomarker for early diagnosis of primary Sjögren’s syndrome: a pilot study	5
The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials	5
Natural language processing to intercept rheumatoid and psoriatic arthritis from clinical notes in the Emergency Department	4
Association between impaired lung function and risk of spondyloarthritis: a cross-sectional study in the UK Biobank	4
Cardiometabolic disease and risk of total knee arthroplasty among patients with knee osteoarthritis receiving intra-articular hyaluronic acid: a real-world cohort study	4
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort	4
Retraction notice	4
Incidence rate of and risk factors for glomerulonephritis in patients with axial spondyloarthritis: a nationwide population-based study	4

Restricted cubic spline analysis of treatment duration before tocilizumab withdrawal and relapse risk in rheumatoid arthritis	4
Orthopaedic physicians’ awareness, diagnostic challenges and referral barriers in axial spondyloarthritis: insights from a nationwide survey in Germany	4
The impact of psoriatic arthritis on quality of life: a systematic review	4
Comparison of clinical efficiency between intra-articular injection of platelet-rich plasma and hyaluronic acid for osteoarthritis: a meta-analysis of randomized controlled trials	4
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthri	4
Definition of the terms used to describe psoriatic disease datasets: a HIPPOCRATES initiative	4
To flare or not to flare: patients’ and rheumatologists’ perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis	4
Advancing artificial intelligence in rheumatology from evidence to practice	4
SCORE2 is superior to SCORE in predicting the presence of carotid plaques and intima-media thickness in rheumatoid arthritis patients: a cross-sectional study using carotid ultrasound	4
New insights in lower limb reconstruction strategies	4
A procedure in decline: frequency of temporal artery biopsies since 2017 in a major Danish ophthalmology center	4
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis	3
A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis	3
Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review	3
Patient and public involvement in musculoskeletal pain research: using mutual learning to improve research quality	3
Diagnosis and therapeutic management of psoriatic arthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA)	3
Monotherapy or combination therapy in PsA: current aspects	3
Vertebral fractures and bone health in patients with chronic non-bacterial osteomyelitis at disease onset: insights from the monocentric CAMELOT cohort	3
RAGing ahead in rheumatology: new language model architectures to tame artificial intelligence	3
Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA database	3
MCCs in adults with autoimmune and inflammatory rheumatic diseases: evidence to date and future directions	3
Capsular stem cell function and tissue composition are associated with symptoms and radiographic severity in people with knee osteoarthritis	3
Double positivity for anti-dsDNA and anti-Sm antibodies represents higher disease activity in systemic lupus erythematosus	3
Risk factors for acute coronary syndrome in patients with giant cell arteritis: a scoping review	3
Effects of TNF-α inhibition versus secukinumab on active ultrasound-confirmed enthesitis in psoriatic arthritis	3
Imaging-guided stratification in giant cell arteritis: prognostic and therapeutic implications	3
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exp	3
Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy	3
Association of an app-based intervention with improvements in mobility, trunk muscle strength and patient-reported disease activity in axial spondyloarthritis: a 24-week pre–post study	3
Cardiovascular comorbidities in psoriatic arthritis: state of the art	3
Regenerative medicine for early osteoarthritis	3
Innovations in Genicular Outcomes Registry (IGOR): protocol for a real-world registry study of treatments for knee osteoarthritis	3
Effectiveness of high-frequency repetitive transcranial magnetic stimulation combined with quadriceps strength training in the treatment of knee osteoarthritis: a randomized controlled trial	3
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experience	2
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib	2
Utilising a non-surgical intervention in the knee osteoarthritis care pathway: a 6-year retrospective audit on NHS patients	2
Underestimation of fracture risk by conventional FRAX thresholds in axial spondyloarthritis: a proposal for disease-specific thresholds	2
The neutrophil-to-lymphocyte ratio as a surrogate marker for disease activity in systemic lupus erythematosus: a correlation study using the SLE-DAS	2
Risk factors and prognosis of depression in Takayasu arteritis patients	2
Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study	2
Deep learning meets chest X-rays: a promising approach for predicting future compression fracture risk	2
Early-stage hypertension defined by the 2017 ACC/AHA blood pressure guideline carries excessive cardiovascular risk in axial spondyloarthritis patients	2
Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice	2
Consensus statements on the transition care for adolescents with rheumatic diseases in Saudi Arabia	2
Tracking global quality of life trajectories in knee osteoarthritis: a population-based long-term analysis	2
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of OR	2
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the H	2
Temporal trends and future projections of hand osteoarthritis burden in China from 1990 to 2021	2
Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide, pop	2
Switching from rituximab originator to GP2013 or CT-P10 biosimilars in autoimmune rheumatic diseases: drug retention rate and safety data from a multicentric retrospective cohort	2
Effectiveness of dry needling combined with exercise therapy versus exercise alone for pain and functional outcomes in knee osteoarthritis: a systematic review and meta-analysis of randomized controll	2